247 related articles for article (PubMed ID: 10676770)
1. Thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Baker KR; Moake JL
Curr Opin Pediatr; 2000 Feb; 12(1):23-8. PubMed ID: 10676770
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Moake JL
Arch Pathol Lab Med; 2002 Nov; 126(11):1430-3. PubMed ID: 12421153
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
4. [Thrombotic thrombocytopenic purpura in children -- pathophysiologic mechanisms and their clinical significance].
Korczowski B
Med Wieku Rozwoj; 2005; 9(4):753-61. PubMed ID: 16733283
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in thrombotic thrombocytopenic purpura.
Sadler JE; Moake JL; Miyata T; George JN
Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
Elliott MA; Nichols WL
Mayo Clin Proc; 2001 Nov; 76(11):1154-62. PubMed ID: 11702904
[TBL] [Abstract][Full Text] [Related]
9. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
10. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
11. Platelets: thrombotic thrombocytopenic purpura.
George JN; Sadler JE; Lämmle B
Hematology Am Soc Hematol Educ Program; 2002; ():315-34. PubMed ID: 12446430
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
Polito MG; Kirsztajn GM
J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
[TBL] [Abstract][Full Text] [Related]
13. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
Furlan M
Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic thrombocytopenic purpura: the systemic clumping "plague".
Moake JL
Annu Rev Med; 2002; 53():75-88. PubMed ID: 11818464
[TBL] [Abstract][Full Text] [Related]
15. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
Furlan M; Lämmle B
Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.
Schneppenheim R; Budde U; Oyen F; Angerhaus D; Aumann V; Drewke E; Hassenpflug W; Häberle J; Kentouche K; Kohne E; Kurnik K; Mueller-Wiefel D; Obser T; Santer R; Sykora KW
Blood; 2003 Mar; 101(5):1845-50. PubMed ID: 12393505
[TBL] [Abstract][Full Text] [Related]
17. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Bosch T; Wendler T
Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.
Arai S; Allan C; Streiff M; Hutchins GM; Vogelsang GB; Tsai HM
Hematol J; 2001; 2(5):292-9. PubMed ID: 11920264
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and laboratory findings of thrombotic thrombocytopenic purpura associated with ticlopidine].
Yagi H
Rinsho Byori; 2005 Jul; 53(7):630-8. PubMed ID: 16104532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
